Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01196689 | Pharmacokinetics in Adolescents | PHASE1 | COMPLETED | 21 | — | — | Oct 1, 2010 | Feb 1, 2011 | Mar 7, 2011 | 1 | Sweden |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | AZD1981 100 mg twice daily for 6 ½ days |
| Name | Type | Description |
|---|---|---|
| AZD1981 100 mg twice daily for 61/2 days | DRUG | 100 mg tablets |
Inclusion Criteria: * Provision of informed consent prior to any study specific procedures * A minimum of 6 months documented history of asthma * Be a non-smoker or ex-smoker who has stopped smoking for \>6 months prior to Visit 1 (pre-entry) Exclusion Criteria: * Any clinically significant disea...